Changing picture of cellular drug resistance in human leukemia (Q35749778)

10 August 2017

1 reference

title

Changing picture of cellular drug resistance in human leukemia (English)

1 reference

10 August 2017

Jan Maxwell Nørgaard

1

0 references

Peter Hokland

object named as

Peter Hokland

series ordinal

3

0 references

author name string

Lene Hyldahl Olesen

series ordinal

2

1 reference

10 August 2017

publication date

1 April 2004

1 reference

Critical Reviews in Oncology Hematology

10 August 2017

published in

1 reference

10 August 2017

volume

50

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

39-49

1 reference

Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

The human ATP-binding cassette (ABC) transporter superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Reaction path of protein farnesyltransferase at atomic resolution

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Multidrug resistance is more than MDR1 activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Clarification of the chromosomal assignment of the human P-glycoprotein/mdr1 gene: possible coincidence with the cystic fibrosis and c-met oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

MDR1 gene expression and drug resistance of AML cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Correlation of MDR1 /P-170 expression with daunorubicin uptake and sensitivity of leukemic progenitors in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Modifiers of multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Different modes of anthracycline interaction with topoisomerase II. Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia gene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Childhood acute lymphoblastic leukaemia--current status and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Two groups of Philadelphia chromosome-positive childhood acute lymphoblastic leukemia classified by pretreatment multidrug sensitivity or resistance in in vitro testing

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Inv(16) acute myeloid leukemia cells show an increased sensitivity to cytosine arabinoside in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

MDR1 and MRP expression in chronic B-cell lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Multidrug resistance mechanisms in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Ph(+) acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Primary Bioassay of Human Tumor Stem Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Use of in vitro tests in predictive cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Susceptibility of acute myeloid leukemia (AML) cells from clinically resistant and sensitive patients to daunomycin (DNR): assessment in vitro after stimulation with colony stimulating factors (CSFs).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

GM-CSF incubation prior to treatment with cytarabine or doxorubicin enhances drug activity against AML cells in vitro: a model for leukemia chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Mitochondria and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Caspases: enemies within

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

The Bcl-2 protein family: arbiters of cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

The multidrug resistance phenotype confers immunological resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

p53 may mediate the mdr-1 expression via the WT1 gene in human vincristine-resistant leukemia/lymphoma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

The drug resistance-related protein LRP is the human major vault protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

P-glycoprotein and multidrug resistance-associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Spontaneous overexpression of the long form of the Bcl-X protein in a highly resistant P388 leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

The kiss of death: promises and failures of death receptors and ligands in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling. Implications for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

1 reference

7 January 2021

Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

1 reference

7 January 2021

Bax suppresses tumorigenesis and stimulates apoptosis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900173-2

7 January 2021

10.1016/S1040-8428(03)00173-2

Identifiers

DOI

1 reference

10 August 2017

1 reference